サマリー

世界の男性性腺機能低下症市場 2022-2026 年
Technavioは男性性腺機能低下症市場を監視しており、2022-2026年の間に6億8495万ドルの成長が見込まれ、予測期間中にCAGR5.09%で進行しています。当レポートでは、男性性腺機能低下症市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などをお届けします。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。男性性腺機能低下症の発生率の増加、男性性腺機能低下症とその治療オプションに関する認知度の向上、不妊率の上昇などが市場を牽引しています。
男性性腺機能低下症市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioの男性性腺機能低下症市場は、以下のように区分されています。
タイプ別
- クラインフェルタース症候群
- カルマン症候群
- 下垂体障害
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本研究では、今後数年間の男性性腺機能低下症市場の成長を促進する主要な理由の一つとして、市場の成長を促進する可能性が高い無機的な成長戦略の増加を特定しています。また、パイプラインに燃料を供給する堅牢な研究開発活動、低テストステロンレベルの治療は、COVID-19死亡率を減らすことができ、市場での大規模な需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約する方法で、主要パラメータの分析により、市場の詳細な図を提示します。男性性腺機能低下症市場に関する当レポートの対象領域は次のとおりです。
- 男性性腺機能低下症市場のサイジング
- 男性性腺機能低下症市場の予測
- 男性性腺機能低下症市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc、Aytu BioPharma Inc、Bayer AG、Bio Techne Corp、Diornal Group Plc、Eli Lilly and Co、Endo International Plc、Fering B.V., IBSA Institute Biochimique SA、Lipocine Inc,メルク・アンド・カンパニー、ペリゴ・カンパニー、Merck and Co.Inc.、Perrigo Co.Plc、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.など。また、男性性腺機能低下症市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/male-hypogonadism-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Klinefelters syndrome - Market size and forecast 2021-2026
o Exhibit 28: Chart on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
o 5.4 Kallmann syndrome - Market size and forecast 2021-2026
o Exhibit 32: Chart on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
o 5.5 Pituitary disorders - Market size and forecast 2021-2026
o Exhibit 36: Chart on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Pituitary disorders - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Pituitary disorders - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Type
o Exhibit 40: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. - Overview
o Exhibit 90: AbbVie Inc. - Product / Service
o Exhibit 91: AbbVie Inc. - Key offerings
o 10.4 Bayer AG
o Exhibit 92: Bayer AG - Overview
o Exhibit 93: Bayer AG - Business segments
o Exhibit 94: Bayer AG - Key offerings
o Exhibit 95: Bayer AG - Segment focus
o 10.5 Eli Lilly and Co.
o Exhibit 96: Eli Lilly and Co. - Overview
o Exhibit 97: Eli Lilly and Co. - Product / Service
o Exhibit 98: Eli Lilly and Co. - Key offerings
o 10.6 Endo International Plc
o Exhibit 99: Endo International Plc - Overview
o Exhibit 100: Endo International Plc - Business segments
o Exhibit 101: Endo International Plc - Key news
o Exhibit 102: Endo International Plc - Key offerings
o Exhibit 103: Endo International Plc - Segment focus
o 10.7 Ferring B.V.
o Exhibit 104: Ferring B.V. - Overview
o Exhibit 105: Ferring B.V. - Product / Service
o Exhibit 106: Ferring B.V. - Key offerings
o 10.8 IBSA Institute Biochimique SA
o Exhibit 107: IBSA Institute Biochimique SA - Overview
o Exhibit 108: IBSA Institute Biochimique SA - Product / Service
o Exhibit 109: IBSA Institute Biochimique SA - Key offerings
o 10.9 Lipocine Inc.
o Exhibit 110: Lipocine Inc. - Overview
o Exhibit 111: Lipocine Inc. - Product / Service
o Exhibit 112: Lipocine Inc. - Key offerings
o 10.10 Merck and Co. Inc.
o Exhibit 113: Merck and Co. Inc. - Overview
o Exhibit 114: Merck and Co. Inc. - Business segments
o Exhibit 115: Merck and Co. Inc. - Key news
o Exhibit 116: Merck and Co. Inc. - Key offerings
o Exhibit 117: Merck and Co. Inc. - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 118: Pfizer Inc. - Overview
o Exhibit 119: Pfizer Inc. - Product / Service
o Exhibit 120: Pfizer Inc. - Key news
o Exhibit 121: Pfizer Inc. - Key offerings
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 122: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 123: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 126: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Pituitary disorders - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Pituitary disorders - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Bayer AG - Overview
Exhibits93: Bayer AG - Business segments
Exhibits94: Bayer AG - Key offerings
Exhibits95: Bayer AG - Segment focus
Exhibits96: Eli Lilly and Co. - Overview
Exhibits97: Eli Lilly and Co. - Product / Service
Exhibits98: Eli Lilly and Co. - Key offerings
Exhibits99: Endo International Plc - Overview
Exhibits100: Endo International Plc - Business segments
Exhibits101: Endo International Plc - Key news
Exhibits102: Endo International Plc - Key offerings
Exhibits103: Endo International Plc - Segment focus
Exhibits104: Ferring B.V. - Overview
Exhibits105: Ferring B.V. - Product / Service
Exhibits106: Ferring B.V. - Key offerings
Exhibits107: IBSA Institute Biochimique SA - Overview
Exhibits108: IBSA Institute Biochimique SA - Product / Service
Exhibits109: IBSA Institute Biochimique SA - Key offerings
Exhibits110: Lipocine Inc. - Overview
Exhibits111: Lipocine Inc. - Product / Service
Exhibits112: Lipocine Inc. - Key offerings
Exhibits113: Merck and Co. Inc. - Overview
Exhibits114: Merck and Co. Inc. - Business segments
Exhibits115: Merck and Co. Inc. - Key news
Exhibits116: Merck and Co. Inc. - Key offerings
Exhibits117: Merck and Co. Inc. - Segment focus
Exhibits118: Pfizer Inc. - Overview
Exhibits119: Pfizer Inc. - Product / Service
Exhibits120: Pfizer Inc. - Key news
Exhibits121: Pfizer Inc. - Key offerings
Exhibits122: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits123: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits124: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits125: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits126: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations